Clinical Practice Guidelines
The Clinical Practice Guidelines, based on the latest evidence and six years of work, recommend best practices on testing for Alpha-1, Alpha-1 lung and liver disease, and when augmentation therapy should be prescribed, among other recommendations. The guidelines are intended to update a 2003 document from the American Thoracic Society (ATS) and the European Respiratory Society on the diagnosis and management of Alpha-1.
Robert A. Sandhaus, MD, PhD, one of the authors of the Clinical Practice Guidelines, gave an overview and answered questions and concerns about the guidelines at the 2016 Alpha-1 National Education Conference. View the video below: